Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Glucagon in GIGD in Type 2 Diabetes
NCT02669524Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adomeglivant in type 2 diabetes mellitus (T2DM), sponsored by Gentofte Hospital. Started Oct 2015; status: completed.
02
Drugs
adomeglivant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02669524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669524.